11 Mar 2024 A new partnership will provide end-to-end solutions from sample to report for whole genome nanopore sequencing reads at scale in future clinical.
Oxford Nanopore Technologies plc (Oxford Nanopore), the company delivering a new generation of nanopore-based molecular sensing technology, and SeqOne, the leading AI-driven genomic decision support software, today announced a new partnership.
The Undiagnosed Diseases Network Foundation (UDNF) joins forces with patient advocacy organizations around the globe to shine a light on undiagnosed diseases.
Herndon, Virginia (PRWEB) February 22, 2022 Rare diseases affect an estimated 350 million people globally spanning more than 7,000 known conditions. And